|
[1]
|
Goodoory, V.C., Houghton, L.A., Black, C.J. and Ford, A.C. (2022) Characteristics of, and Natural History Among, Individuals with Rome IV Functional Bowel Disorders. Neurogastroenterology & Motility, 34, e14268. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sperber, A.D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U.C., Gwee, K.A., et al. (2017) The Global Prevalence of IBS in Adults Remains Elusive Due to the Heterogeneity of Studies: A Rome Foundation Working Team Literature Review. Gut, 66, 1075-1082. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wei, L., Singh, R., Ro, S. and Ghoshal, U.C. (2021) Gut Microbiota Dysbiosis in Functional Gastrointestinal Disorders: Underpinning the Symptoms and Pathophysiology. JGH Open, 5, 976-987. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Luo, Q., Zhou, D., He, J., Liu, J., Xu, B., Fan, H., et al. (2025) Relationships between Emotional States, Bipolar Disorder, and Gastrointestinal Disorders: A Two-Sample Mendelian Randomization Study. Journal of Affective Disorders, 369, 475-482. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hu, L., Huang, X., Liu, S., Fang, L., Zhang, J. and Tang, X. (2025) The Impact of Carbohydrate Quality on Gut Health: Insights from the NHANES. PLOS ONE, 20, e0315795. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Su, Y., Su, X., Chen, Z., Wang, L. and Chen, J. (2026) Bibliometric and Visual Analysis of Gut Microbiota Research in Functional Bowel Disorders from 2016 to 2025. Frontiers in Medicine, 13, Article ID: 1735121. [Google Scholar] [CrossRef]
|
|
[7]
|
Black, C.J., Drossman, D.A., Talley, N.J., Ruddy, J. and Ford, A.C. (2020) Functional Gastrointestinal Disorders: Advances in Understanding and Management. The Lancet, 396, 1664-1674. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Dale, H.F. and Lied, G.A. (2020) Gut Microbiota and Therapeutic Approaches for Dysbiosis in Irritable Bowel Syndrome: Recent Developments and Future Perspectives. Turkish Journal of Medical Sciences, 50, 1632-1641. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Arbabi, F., Shapoury, R., Haghi, F., Zeighami, H. and Pirzeh, R. (2024) Investigating the Bacterial Profiles of Lactobacillus, Bifidobacterium, Actinobacteria, Fusobacterium, Firmicutes, and Bacteroides in Stool Samples from Patients with Severe Depression and Healthy Individuals. Psychoneuroendocrinology, 170, Article 107090. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wang, Y.L., Xu, X.Q., Long, Y.Y. and Cheng, Y. (2025) Characterization of Gut Microbiota and Metabolites in Individuals with Constipation-Predominant Irritable Bowel Syndrome. Frontiers in Microbiology, 16, Article ID: 1617288. [Google Scholar] [CrossRef]
|
|
[11]
|
Teige, E.S., Hillestad, E.M.R., Steinsvik, E.K., Brønstad, I., Lundervold, A., Lundervold, A.J., et al. (2024) Fecal Bacteria and Short‐Chain Fatty Acids in Irritable Bowel Syndrome: Relations to Subtype. Neurogastroenterology & Motility, 36, e14854. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Jacobs, J.P., Lagishetty, V., Hauer, M.C., Labus, J.S., Dong, T.S., Toma, R., et al. (2023) Multi-Omics Profiles of the Intestinal Microbiome in Irritable Bowel Syndrome and Its Bowel Habit Subtypes. Microbiome, 11, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ma, X., Liu, J., Jiang, L., Gao, Z., Shi, Z., Zhang, N., et al. (2025) Dynamic Changes in the Gut Microbiota Play a Critical Role in Age-Associated Cognitive Dysfunction via SCFAs and LPS Synthesis Metabolic Pathways during Brain Aging. International Journal of Biological Macromolecules, 304, Article 140945. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhan, K., Wu, H., Xu, Y., Rao, K., Zheng, H., Qin, S., et al. (2024) The Function of the Gut Microbiota-Bile Acid-TGR5 Axis in Diarrhea-Predominant Irritable Bowel Syndrome. mSystems, 9, e01299-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Yang, Q., Cai, Y., Guo, S., Wang, Z., Wang, Y., Yu, X., et al. (2023) Decoding Immune Interactions of Gut Microbiota for Understanding the Mechanisms of Diseases and Treatment. Frontiers in Microbiology, 14, Article 1238822. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wu, S., Jia, W., Li, J., Luo, Y., Chen, F., Yang, T., et al. (2025) Infant Gut Microbiota and SCFAs Mediate the Association between Early-Life Human Milk Microbiota and Neurodevelopment. npj Biofilms and Microbiomes, 11, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Gomaa, E.Z. (2020) Human Gut Microbiota/Microbiome in Health and Diseases: A Review. Antonie van Leeuwenhoek, 113, 2019-2040. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wu, H., Zhan, K., Rao, K., Zheng, H., Qin, S., Tang, X., et al. (2022) Comparison of Five Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Rat Models in the Brain-Gut-Microbiota Axis. Biomedicine & Pharmacotherapy, 149, Article 112811. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhang, H., Wang, G., Xiong, Z., Liao, Z., Qian, Y., Song, X., et al. (2024) lactobacillus Plantarum AR495 Improves Stress-Induced Irritable Bowel Syndrome in Rats by Targeting Gut Microbiota and Mast Cell-Par2-Trpv1 Signaling Pathway. Food Science and Human Wellness, 13, 698-708. [Google Scholar] [CrossRef]
|
|
[20]
|
Caceres Lessa, A.Y., Edwinson, A., Sato, H., Yang, L., Berumen, A., Breen-Lyles, M., et al. (2025) Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 23, 632-643.E13. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Chen, J., Zhao, T., Li, H., Xu, W., Maas, K., Singh, V., et al. (2024) Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome. International Journal of Molecular Sciences, 25, Article 3514. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Deng, W., Yi, P., Xiong, Y., Ying, J., Lin, Y., Dong, Y., et al. (2024) Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia. Aging and Disease, 15, Article 480. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Sun, Y., Li, D., Zhao, L., Liu, X., Guan, K., Ma, Y., et al. (2025) PYY-Mediated Appetite Control and Obesity Alleviation through Short-Chain Fatty Acid-Driven Gut-Brain Axis Modulation by Lacticaseibacillus rhamnosus HF01 Isolated from Qula. Journal of Dairy Science, 108, 7960-7978. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chenghan, M., Wanxin, L., Bangcheng, Z., Yao, H., Qinxi, L., Ting, Z., et al. (2025) Short‐Chain Fatty Acids Mediate Gut Microbiota-Brain Communication and Protect the Blood-Brain Barrier Integrity. Annals of the New York Academy of Sciences, 1545, 116-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F.M., Reimann, F., et al. (2018) SCFAs Strongly Stimulate PYY Production in Human Enteroendocrine Cells. Scientific Reports, 8, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yue, X., Wen, S., Long-kun, D., Man, Y., Chang, S., Min, Z., et al. (2022) Three Important Short-Chain Fatty Acids (SCFAs) Attenuate the Inflammatory Response Induced by 5-FU and Maintain the Integrity of Intestinal Mucosal Tight Junction. BMC Immunology, 23, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Ma, S., Yeom, J. and Lim, Y. (2022) Specific Activation of Hypoxia-Inducible Factor-2α by Propionate Metabolism via a β-Oxidation-Like Pathway Stimulates MUC2 Production in Intestinal Goblet Cells. Biomedicine & Pharmacotherapy, 155, Article 113672. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Li, E., Wang, J., Guo, B. and Zhang, W. (2025) Effects of Short-Chain Fatty Acid-Producing Probiotic Metabolites on Symptom Relief and Intestinal Barrier Function in Patients with Irritable Bowel Syndrome: A Double-Blind, Randomized Controlled Trial. Frontiers in Cellular and Infection Microbiology, 15, Article ID: 1616066. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
龙水妹, 梁尧. 基于肠道菌群探讨从脾虚论治腹泻型肠易激综合征[J]. 中医药临床杂志, 2025, 37(5): 910-914.
|
|
[30]
|
刘俊宏, 李红芳, 毛兰芳, 等. 基于脑肠轴对肝郁脾虚型肠易激综合征(ibs)肠道微生态及水液代谢组学的研究[R]. 兰州: 甘肃中医药大学附属医院, 2022.
|
|
[31]
|
谢建群, 吴大正, 刘慧蓉, 等. 肠易激综合征的证候病机及其生物学基础研究[R]. 上海: 上海中医药大学, 2010.
|
|
[32]
|
Yang, W., Tan, H. and Nie, S. (2025) A Low-Fodmap Diet Enhances IBS Symptom Relief and Gut Microbiota Homeostasis: A Meta-Analysis. Food Bioscience, 71, Article 107190. [Google Scholar] [CrossRef]
|
|
[33]
|
杨斌, 李超, 朱华军, 等. 低fodmap饮食治疗腹泻型肠易激综合征的效果分析[J]. 现代生物医学进展, 2018, 18(22): 4298-4302.
|
|
[34]
|
Murtaza, N., Collins, L., Yao, C.K., et al. (2025) Effects of Dietary FODMAP Content on the Faecal Microbiome and Gastroin-Testinal Physiology in Healthy Adults: A Randomised, Controlled Cross-Over Feeding Study. British Journal of Nutrition, 134, 712-726.
|
|
[35]
|
Trott, N., Aziz, I., Rej, A. and Surendran Sanders, D. (2019) How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study. Nutrients, 11, Article 1313. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Singh, P., Dean, G., Iram, S., Peng, W., Chey, S.W., Rifkin, S., et al. (2025) Efficacy of Mediterranean Diet vs. Low‐Fodmap Diet in Patients with Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. Neurogastroenterology & Motility, 37, e70060. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Di Rosa, C., Altomare, A., Terrigno, V., Carbone, F., Tack, J., Cicala, M., et al. (2023) Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients, 15, Article 1647. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Khalaidzheva, K.N., Nikitina, N.V., Astrashkova, O.V., Drozdov, V.N., Melkonyan, G.G. and Shikh, E.V. (2024) Features of the Effect of a Probiotic, Containing Lactobacillus and Bifidobacterium on the Intestinal Microbiota and Clinical Symptoms of Irritable Bowel Syndrome. Terapevticheskii Arkhiv, 96, 356-363. [Google Scholar] [CrossRef]
|
|
[39]
|
Yin, P., Yi, S., Du, T., Zhang, C., Yu, L., Tian, F., et al. (2024) Dynamic Response of Different Types of Gut Microbiota to Fructooligosaccharides and Inulin. Food & Function, 15, 1402-1416. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Yao, Q., Zhang, W., Wang, Y., Shi, L., Zhao, Y., Liang, J., et al. (2025) Lactobacillus Plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating Mast Cell Hyperactivation. Nutrients, 17, Article 1670. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Moser, A.M., Spindelboeck, W., Halwachs, B., Strohmaier, H., Kump, P., Gorkiewicz, G., et al. (2018) Effects of an Oral Synbiotic on the Gastrointestinal Immune System and Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. European Journal of Nutrition, 58, 2767-2778 . [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
樊琳, 巩玉钰, 戴春威, 等. 肠道微生物制剂对小儿肠易激综合征肠道菌群、Th1/Th2细胞水平的影响[J]. 现代消化及介入诊疗, 2021, 26(5): 603-606.
|
|
[43]
|
Schmidt, T.S.B., Li, S.S., Maistrenko, O.M., Akanni, W., Coelho, L.P., Dolai, S., et al. (2022) Drivers and Determinants of Strain Dynamics Following Fecal Microbiota Transplantation. Nature Medicine, 28, 1902-1912. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
El-Salhy, M., Hatlebakk, J.G., Gilja, O.H., Bråthen Kristoffersen, A. and Hausken, T. (2019) Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-Blind, Placebo-Controlled Study. Gut, 69, 859-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Huang, Y., Zheng, E., Hu, M., Yang, X., Lan, Q., Yu, Y., et al. (2024) The Impact of Depression-Mediated Gut Microbiota Composition on Irritable Bowel Syndrome: A Mendelian Study. Journal of Affective Disorders, 360, 15-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Huang, H.L., Chen, H.T., Luo, Q.L., Xu, H.M., He, J., Li, Y.Q., et al. (2019) Relief of Irritable Bowel Syndrome by Fecal Microbiota Transplantation Is Associated with Changes in Diversity and Composition of the Gut Microbiota. Journal of Digestive Diseases, 20, 401-408. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Yamane, T., Masaoka, T., Ishii, C., Masuoka, H., Suda, W., Kurokawa, S., et al. (2025) Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel Disorders. Digestion, 106, 469-479. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Liu, C.K., Seo, J., Pravodelov, V., Frazier, S., Guy, M., Concilio, K., et al. (2022) Pilot Study of Autologous Fecal Microbiota Transplants in Nursing Home Residents: Feasibility and Safety. Contemporary Clinical Trials Communications, 27, Article 100906. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
罗茂权, 黄菊芳, 李炜, 等. 中药治疗便秘型肠易激综合征的用药规律[J]. 广西医学, 2022, 44(18): 2123-2127.
|
|
[50]
|
刘丽莎, 王锐, 旭日花, 等. 白术多糖对益生菌的促生长作用及结构分析[J]. 食品科学, 2010, 31(19): 124-128.
|
|
[51]
|
朱燕舞, 余李涛, 陈静. 白术多糖提取分离、结构表征及生物活性研究进展[J]. 中华中医药学刊, 2024, 42(10): 70-79.
|
|
[52]
|
吴莉, 舒青龙, 刘玉琼, 等. 黄芪多糖和炙黄芪多糖调节大鼠肠道菌群组成与多样性的比较研究[J]. 中药药理与临床, 2021, 37(4): 40-47.
|
|
[53]
|
冯文林, 伍海涛. 基于《黄帝内经》“甘入脾”理论指导下健脾中药的多糖成分调控ibs-d肠道菌群的机制研究[J]. 辽宁中医杂志, 2019, 46(1): 127-129.
|
|
[54]
|
牧亚峰, 向楠, 左新河, 等. 白芍总苷对自身免疫性甲状腺炎大鼠肠黏膜屏障及肠道菌群的影响[J]. 中草药, 2021, 52(11): 3269-3277.
|
|
[55]
|
孙聪颖, 钟鑫勤, 赵玉翠, 等. 天然法尼醇x受体激动剂对腹泻型肠易激综合征的治疗潜力[J]. 中南药学, 2024, 22(12): 3295-3303.
|
|
[56]
|
刘畅, 王潇, 刘芳, 等. 厚朴酚对便秘型肠易激综合征大鼠5-ht通路及肠道菌群的影响[J]. 中成药, 2023, 45(9): 3067-3072.
|
|
[57]
|
刘天姿, 李佳轩, 牛建海, 等. 柴胡及其复方对腹泻型与便秘型肠易激综合征的同治作用研究进展[J]. 中国药业, 2026, 35(8): 146-153.
|
|
[58]
|
姚思杰, 王栩芮, 张明明. 痛泻要方对肝郁脾虚型ibs-d患者的临床疗效及其机制[J]. 中国实验方剂学杂志, 2020, 26(12): 107-113.
|
|
[59]
|
张丽敏, 赵清玉, 王一鸣, 等. 基于短链脂肪酸-5-羟色胺转化代谢机制研究痛泻要方对肠易激综合征模型肠道黏膜屏障的作用[J]. 中国药理学通报, 2025, 41(10): 1963-1972.
|
|
[60]
|
黄柳向, 旷思敏, 朱楚月. 痛泻安脾汤对腹泻型肠易激综合征大鼠肠道菌群的影响[J]. 中医药导报, 2020, 26(9): 1-6.
|
|
[61]
|
刘佳星, 王彦礼, 李彧, 等. 四神丸对腹泻型肠易激综合征大鼠肠道菌群影响的实验研究[J]. 药学学报, 2019, 54(4): 670-677.
|
|
[62]
|
章茜, 黎思琪, 胡运莲, 等. 基于肠道菌群及短链脂肪酸探讨四神丸改善腹泻型肠易激综合征脾肾阳虚证大鼠肠屏障功能的作用机制[J]. 中国实验方剂学杂志, 2025, 31(21): 80-89.
|
|
[63]
|
张儒奇, 方志安, 韩文庆, 等. 葛根芩连汤对腹泻型肠易激综合征大鼠肠道菌群的影响[J]. 中国中药杂志, 2022, 47(24): 6709-6719.
|
|
[64]
|
江月斐, 劳绍贤, 邝枣园, 等. 清热化湿复方对腹泻型肠易激综合征脾胃湿热证肠道微生态影响的初步研究[J]. 福建中医学院学报, 2008(4): 1-4.
|
|
[65]
|
周依晨, 叶蔚. 基于“脾为之卫”探讨“肠道微生态-免疫调节”在腹泻型肠易激综合征中的作用[J]. 中医临床研究, 2025, 17(4): 53-56.
|
|
[66]
|
黄发樟, 姚志芳. 16s rRNA测序分析针灸治疗对腹泻型肠易激综合征(肝郁脾虚证)患者肠道菌群的影响[J]. 中国医药导刊, 2024, 26(4): 407-411.
|
|
[67]
|
李湘力, 蔡敬宙, 林泳, 等. 针刺疗法调节ibs-d大鼠肠道菌群结构和促进肠紧密连接的作用研究[J]. 广州中医药大学学报, 2019, 36(7): 1022-1028.
|
|
[68]
|
谢相婷, 张桢, 徐月, 等. “抑肝扶脾”法针刺治疗腹泻型肠易激综合征的临床疗效评价以及对肠道菌群的影响[J/OL]. 重庆医科大学学报: 1-9. https://link.cnki.net/doi/10.13406/j.cnki.cyxb.004096, 2026-06-24.[CrossRef]
|
|
[69]
|
刘霞. 基于16S rDNA和1H NMR技术探讨隔药饼灸对肠易激综合征大鼠肠道菌群和代谢物的影响[D]: [博士学位论文]. 长沙: 湖南中医药大学, 2020.
|
|
[70]
|
郑媛媛. 肠康方联用益生菌中西医结合治疗腹泻型肠易激综合征的临床疗效观察[D]: [硕士学位论文]. 南京: 南京中医药大学, 2021.
|
|
[71]
|
张璐. 逍遥痛泻方合匹维溴铵治疗ibs-d (肝郁脾虚证)的临床观察[D]: [硕士学位论文]. 昆明: 云南中医药大学, 2022.
|
|
[72]
|
张志卓, 张倩, 张立涛, 等. 浮针联合西药治疗肝郁气滞证腹泻型肠易激综合征的临床观察[J]. 广州中医药大学学报, 2026, 43(1): 142-148.
|